Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
Clinical trial NCT04112810 · COMPLETED
Trial details
- NCT number
- NCT04112810
- Sponsor
- Medical College of Wisconsin
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2024-06-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.